Carregant...

Complete remission of critical neurohistiocytosis by vemurafenib

OBJECTIVE: To describe a patient with life-threatening brainstem neurohistiocytosis who recovered completely upon targeted treatment with the V600E mutation-specific BRAF inhibitor vemurafenib. METHODS: We report clinical, histiologic, genetic, and sequential imaging findings, including fluorodeoxyg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Neuroimmunol Neuroinflamm
Autors principals: Euskirchen, Philipp, Haroche, Julien, Emile, Jean-François, Buchert, Ralph, Vandersee, Staffan, Meisel, Andreas
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4345630/
https://ncbi.nlm.nih.gov/pubmed/25745636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000078
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!